Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-30

Clinical Trial Update: Texting to Reduce Human Immunodeficiency Virus (HIV) Risk [NA]

View source ↗

Summary

A Boston University-sponsored clinical trial is recruiting to evaluate whether text messaging can reduce HIV risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Boston University | Conditions: HIV Infections | NA | Status: RECRUITING